The Clostridium difficile proline racemase is not essential for early logarithmic growth and infection

Canadian Journal of Microbiology

Volumn 60, Issue 4, 2014, Pages 251-254

  Wu, Xiaoqian ^a   Hurdle, Julian G ^a  

^a UNIVERSITY OF TEXAS AT ARLINGTON   (United States)

Author keywords

Anti C. difficile target discovery; Stickland metabolism

Indexed keywords

AMINO ACID ISOMERASES; ANIMALS; CLOSTRIDIUM DIFFICILE; COMPUTATIONAL BIOLOGY; CRICETINAE; DRUG DELIVERY SYSTEMS; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HUMANS; MUTAGENESIS, INSERTIONAL; OPERON; VIRULENCE;

EID: 84897485566     PISSN: 00084166     EISSN: 14803275     Source Type: Journal    
DOI: 10.1139/cjm-2013-0903     Document Type: Note

References (15)

1. Bouillaut, L., Self, W.T., and Sonenshein, A.L. 2013. Proline-dependent regulation of Clostridium difficile Stickland metabolism. J. Bacteriol. 195(4): 844-854. doi:10.1128/JB.01492-12.
2. Heap, J.T., Pennington, O.J., Cartman, S.T., and Minton, N.P. 2009. A modular system for Clostridium shuttle plasmids. J. Microbiol. Methods, 78(1): 79-85. doi:10.1016/j.mimet.2009.05.004.
3. Heap, J.T., Kuehne, S.A., Ehsaan, M., Cartman, S.T., Cooksley, C.M., Scott, J.C., and Minton, N.P. 2010. The ClosTron: mutagenesis in Clostridium refined and streamlined. J. Microbiol. Methods, 80(1): 49-55. doi:10.1016/j.mimet.2009.10.018.
4. Hurdle, J.G., O'Neill, A.J., Chopra, I., and Lee, R.E. 2011. Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections. Nat. Rev. Microbiol. 9(1): 62-75. doi:10.1038/nrmicro2474.
5. Jackson, S., Calos, M., Myers, A., and Self, W.T. 2006. Analysis of proline reduction in the nosocomial pathogen Clostridium difficile. J. Bacteriol. 188(24): 8487-8495. doi:10.1128/JB.01370-06.
6. Janoir, C., Deneve, C., Bouttier, S., Barbut, F., Hoys, S., Caleechum, L., et al. 2013. Adaptive strategies and pathogenesis of Clostridium difficile from in vivo transcriptomics. Infect. Immun. 81(10): 3757-3769. doi:10.1128/IAI.00515-13.
7. Janvilisri, T., Scaria, J., Teng, C.H., McDonough, S.P., Gleed, R.D., Fubini, S.L., et al. 2012. Temporal differential proteomes of Clostridium difficile in the pig ileal-ligated loop model. PLoS One, 7(9): e45608. doi:10.1371/journal.pone. 0045608.
8. Karasawa, T., Ikoma, S., Yamakawa, K., and Nakamura, S. 1995. A defined growth medium for Clostridium difficile. Microbiology, 141(2): 371-375. doi:10.1099/ 13500872-141-2-371.
9. Lovitt, R.W., Kell, D.B., and Morris, J.G. 1987. The physiology of Clostridium sporogenes NCIB 8053 growing in defined media. J. Appl. Bacteriol. 62(1): 81-92. doi:10.1111/j.1365-2672.1987.tb02383.x.
10. McDonald, L.C., Lessa, F., Sievert, D., Wise, M., Herrera, R., Gould, C., et al. 2012. Vital signs: preventing Clostridium difficile infections. MMWR, 61(9): 157-162.
11. O'Connor, J.R., Lyras, D., Farrow, K.A., Adams, V., Powell, D.R., Hinds, J., et al. 2006. Construction and analysis of chromosomal Clostridium difficile mutants. Mol. Microbiol. 61(5): 1335-1351. doi:10.1111/j.1365-2958.2006.05315.x.
12. Rupnik, M., Wilcox, M.H., and Gerding, D.N. 2009. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat. Rev. Microbiol. 7(7): 526-536. doi:10.1038/nrmicro2164.
13. Stickland, L.H. 1935. Studies in the metabolism of the strict anaerobes (genus Clostridium). The oxidation of alanine by Cl. sporogenes. IV. The reduction of glycine by Cl. sporogenes. Biochem. J. 29(4): 889-898.
14. Visser, W.F., Verhoeven-Duif, N.M., and de Koning, T.J. 2012. Identification of a human trans-3-hydroxy-L-proline dehydratase, the first characterized member of a novel family of proline racemase-like enzymes. J. Biol. Chem. 287(26): 21654-21662. doi:10.1074/jbc.M112.363218.
15. Wu, X., Cherian, P.T., Lee, R.E., and Hurdle, J.G. 2013. The membrane as a target for controlling hypervirulent Clostridium difficile infections. J. Antimicrob. Chemother. 68(4): 806-815. doi:10.1093/jac/dks493.